Physician profile
Marc Schechter
NPI 1255436945
$1,819.17
in general payments reported to CMS, 2019-2025
18 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $160 · 2021: $625 · 2022: $334 · 2023: $60.21 · 2024: $20.77 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $395.48 | 2019-2025 | Ubrelvy |
| Novartis Pharmaceuticals Corporation | $287.69 | 2019-2023 | |
| Pfizer INC. | $222.63 | 2020-2025 | |
| Glaxosmithkline, LLC. | $205.22 | 2020-2025 | Shingrix, Arexvy |
| Amgen INC. | $176.51 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $104.85 | 2021-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Biohaven Pharmaceuticals, INC. | $87.80 | 2021 | |
| Eisai INC. | $61.14 | 2021-2025 | |
| Esperion Therapeutics, INC. | $56.94 | 2025 | Nexletol |
| Almatica Pharma LLC | $54.38 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.00 | 2019 | |
| Vistapharm, INC. | $26.28 | 2021 | |
| Insightec,INC | $22.84 | 2025 | Exablate |
| Clarus Therapeutics INC. | $19.62 | 2021 | |
| Novo Nordisk INC | $17.02 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.78 | 2019 | |
| Sanofi Pasteur INC. | $15.29 | 2019 | |
| Althera Pharmaceuticals LLC | $7.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Schechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.